Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis Confirms Interest In Study Of Intestinal Microbiota

Oct 17 (Reuters) - VALBIOTIS SAS  ALVAL.PA :
    * VALBIOTIS CONFIRMS ITS INTEREST IN THE STUDY OF THE
INTESTINAL
MICROBIOTA, A PROMISING FIELD IN THE PREVENTION OF METABOLIC
DISEASES
    * VALBIOTIS COMPILES A BASE OF HUMAN DATA IN FIELD OF
METABOLIC
DISEASES, WITH HIGH VALUE POTENTIAL
    * VALBIOTIS FOCUSES ON FRENCH POPULATION'S UNDERSTANDING OF
INTESTINAL MICROBIOTA THROUGH AN UNPRECEDENTED OPINÉA SURVEY
    * VALBIOTIS DEVELOPS LEADING EXPERTISE IN THIS FIELD OF
RESEARCH

Source text for Eikon:  ID:nBwbWYTTTa 
Further company coverage:  ALVAL.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Valbiotis SA

See all news